Kathleen Ford's most recent trade in Kura Oncology Inc was a trade of 1,813 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Jan. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 27 Jan 2026 | 1,813 | 153,560 (0%) | 0% | 8.5 | 15,339 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 100,000 | 100,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 50,000 | 155,373 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 48,900 | 112,275 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 13 Nov 2025 | 6,902 | 105,373 (0%) | 0% | 11.2 | 77,143 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2025 | 48,900 | 70,267 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 27 Sep 2025 | 6,892 | 63,375 (0%) | 0% | 8.9 | 61,630 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.28 per share. | 19 May 2025 | 1,558 | 21,367 (0%) | 0% | 6.3 | 9,777 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 1,817 | 21,367 (0%) | 0% | 7.9 | 14,303 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 18 Nov 2024 | 526 | 23,184 (0%) | 0% | 16.0 | 8,434 | Common Stock |
| Kura Oncology Inc | Ford Kathleen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 1,496 | 21,602 (0%) | 0% | 17.8 | 26,630 | Common Stock |
| Kura Oncology Inc | Ford Kathleen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 1,821 | 21,214 (0%) | 0% | 13.9 | 25,294 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 171,000 | 171,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,900 | 23,035 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 15 Mar 2021 | 6,250 | 0 (0%) | 0% | 29.4 | 183,951 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 6,250 | 215,625 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 15 Mar 2021 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |